Pirelli & C. S.p.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3672
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:自動車
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Pirelli & C. S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

Pirelli & C. S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pirelli & C. S.p.A. (Pirelli or ‘the group’) is a Italian tyres manufacturing company. The group is manufacturing, distributing and marketing of tyres for cars, motor cycles, cycles and industrial as well as commercial vehicles such as trucks. It provides its products to high value cars, motor cycles, cycles and trucks manufacturing companies across the globe. Under cars, the group’s key products include PZero, Cinturato, Scorpion and Winter. The motor cycles, the group’s products include Pirelli and Metzeler.Under Pirelli, the group offers Diablo and Scorpian. The group provides Roadtec01 and Marathon products under Metzeler. Under bicycle, the group offers PZero Velo product. Pirelli is organized under the laws of the Republic of Italy. The group operates in Italy, Russia, Central/South America, Europe, NAFTA (North America Free Trade Agreement), Asia Pacific, Africa, and Middle East. Pirelli is headquartered in Milan, Italy.

Scope

- Detailed information on Pirelli & C. S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pirelli & C. S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of Pirelli & C. S.p.A. including a breakdown and examination of key business segments
- Intelligence on Pirelli & C. S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pirelli & C. S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pirelli & C. S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pirelli & C. S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pirelli & C. S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Pirelli & C. S.p.A.: Company Overview 9
Pirelli & C. S.p.A.: Overview and Key Facts 9
Pirelli & C. S.p.A.: Overview 9
Pirelli & C. S.p.A.: Key Facts 9
Pirelli & C. S.p.A.: Key Employees 11
Pirelli & C. S.p.A.: Key Employee Biographies 13
Pirelli & C. S.p.A.: Major Products and Services 14
Pirelli & C. S.p.A.: Company History 15
Pirelli & C. S.p.A.: Management Statement 20
Pirelli & C. S.p.A.: Locations and Subsidiaries 22
Pirelli & C. S.p.A.: Key Competitors 23
Pirelli & C. S.p.A.: Company Analysis 24
Pirelli & C. S.p.A.: Business Description 24
Pirelli & C. S.p.A.: SWOT Analysis 25
Pirelli & C. S.p.A.: SWOT Overview 25
Pirelli & C. S.p.A.: Strengths 25
Pirelli & C. S.p.A.: Weaknesses 26
Pirelli & C. S.p.A.: Opportunities 26
Pirelli & C. S.p.A.: Threats 27
Pirelli & C. S.p.A.: Corporate Financial Deals Activity 28
Pirelli & C. S.p.A.: Financial Deals Overview 28
Pirelli & C. S.p.A.: Targets and Partners 29
Pirelli & C. S.p.A.: Top Deals 2014 – 2018YTD* 30
Pirelli & C. S.p.A.: Advisors 31
Pirelli & C. S.p.A.: Top Financial Advisors 31
Pirelli & C. S.p.A.: Mergers and Acquisitions 32
Pirelli & C. S.p.A.: Divestments 33
Pirelli & C. S.p.A.: Private Equity and Ownership 34
Pirelli & C. S.p.A.: Recent Developments 35
Pirelli & C. S.p.A.: News and Events Summary 35
Pirelli & C. S.p.A.: Business Expansion 36
Pirelli & C. S.p.A.: Contracts 37
Pirelli & C. S.p.A.: Financial Deals 38
Pirelli & C. S.p.A.: Market Developments 38
Pirelli & C. S.p.A.: Strategy and Operations 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: Pirelli & C. S.p.A.: Key Facts
Table 2: Pirelli & C. S.p.A.: Key Employees
Table 3: Pirelli & C. S.p.A.: Locations and Subsidiaries
Table 4: Pirelli & C. S.p.A.: Key Competitors
Table 5: Pirelli & C. S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Pirelli & C. S.p.A.: Targets and Partners
Table 7: Pirelli & C. S.p.A.: Top Deals 2014 - 2018YTD*
Table 8: Pirelli & C. S.p.A.: Financial Advisor Ranking by Value (US$m)
Table 9: Pirelli & C. S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Pirelli & C. S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Pirelli & C. S.p.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 12: Pirelli & C. S.p.A.: Divestments by Geography (2014 - YTD*2018)
Table 13: Pirelli & C. S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 14: Pirelli & C. S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 15: Pirelli & C. S.p.A.: News and Events Summary
Table 16: Pirelli & C. S.p.A.: Business Expansion
Table 17: Pirelli & C. S.p.A.: Contracts
Table 18: Pirelli & C. S.p.A.: Financial Deals
Table 19: Pirelli & C. S.p.A.: Market Developments
Table 20: Pirelli & C. S.p.A.: Strategy and Operations

List of Figures
Figure 1: Pirelli & C. S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Pirelli & C. S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Pirelli & C. S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Pirelli & C. S.p.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 5: Pirelli & C. S.p.A.: Divestments by Geography (2014 - YTD*2018)
Figure 6: Pirelli & C. S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Pirelli & C. S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Pirelli & C. S.p.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • AutoNation, Inc.:企業の戦略・SWOT・財務情報
    AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析
    Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • HSBC Finance Corporation:企業の戦略・SWOT・財務情報
    HSBC Finance Corporation - Strategy, SWOT and Corporate Finance Report Summary HSBC Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Suncor Energy Inc (SU):企業の財務・戦略的SWOT分析
    Suncor Energy Inc (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kangmei Pharmaceutical Co Ltd (600518):製薬・医療:M&Aディール及び事業提携情報
    Summary Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Kangmei products include Chinese herbal medicine, bottled single product, hong mei life, xinkaihe senate, chinese medicine derived, medici …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Ahn-Gook Pharmaceutical Co Ltd (001540)-製薬・医療分野:企業M&A・提携分析
    Summary Ahn-Gook Pharmaceutical Co Ltd (Ahn-Gook Pharmaceutical) is a developer and supplier of medicines. The company provides health functional food, medical device, ethical drug, over the counter drugs, and others. Its products include acefenac tab, ahngook carvedilol tab, ahngook cefaclor cap, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆